Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316064 | SCV000847522 | likely benign | Inborn genetic diseases | 2019-11-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000960344 | SCV001107312 | benign | Adrenoleukodystrophy | 2023-12-19 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000960344 | SCV002045853 | benign | Adrenoleukodystrophy | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000960344 | SCV002084592 | likely benign | Adrenoleukodystrophy | 2019-10-28 | no assertion criteria provided | clinical testing |